Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-02-28 Tax Withholding | 2021-03-02 7:40 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 33 | $2.39 | 39,125 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 8:00 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 22,500 | $0 | 39,158 (Direct) | View |
| 2021-01-31 Tax Withholding | 2021-02-02 8:00 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 36 | $2.62 | 39,158 (Direct) | View |
| 2020-12-31 Tax Withholding | 2021-01-05 5:14 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 30 | $2.42 | 16,694 (Direct) | View |
| 2020-11-30 Tax Withholding | 2020-12-01 8:21 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $0.427 | 167,240 (Direct) | View |
| 2020-10-31 Tax Withholding | 2020-11-02 7:07 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $0.4955 | 167,541 (Direct) | View |
| 2020-09-30 Tax Withholding | 2020-10-01 4:31 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $0.533 | 167,842 (Direct) | View |
| 2020-08-31 Tax Withholding | 2020-09-02 5:15 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $0.6194 | 168,143 (Direct) | View |
| 2020-07-31 Tax Withholding | 2020-08-04 4:08 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $0.76 | 168,444 (Direct) | View |
| 2020-06-30 Tax Withholding | 2020-07-02 4:07 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $0.6746 | 168,745 (Direct) | View |
| 2020-05-31 Tax Withholding | 2020-06-03 06:06 am | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $1.14 | 169,046 (Direct) | View |
| 2020-04-30 Tax Withholding | 2020-05-04 6:32 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $0.5483 | 169,347 (Direct) | View |
| 2020-03-31 Tax Withholding | 2020-04-02 5:47 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $0.575 | 169,648 (Direct) | View |
| 2020-02-28 Tax Withholding | 2020-03-03 9:31 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $1.35 | 169,949 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-10 8:30 pm | N/A 2030-02-05 | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 315,000 | $0 | 368,705 (Direct) | View |
| 2020-01-31 Tax Withholding | 2020-02-04 8:56 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 4,295 | $1.35 | 111,705 (Direct) | View |